CanSino Biologics Inc. - Class H


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


CanSino Biologics Inc is China based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as quadrivalence (ACYW135) meningococcal conjugate vaccine, pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated towards development of new vaccine like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

Contact Information

Main Phone: +86 2258213600
Address: 185 South Avenue
Address 2: 401-420, 4th Floor, Biomedical Park
City / Town: Tianjin
Country: CN

Issuer Information

Exchange: OTO
Employees: 516

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A